首页> 外文期刊>Вестник офтальмологии >Use of physiological reparation regulators in glaucoma surgery: a clinicoimmunological study
【24h】

Use of physiological reparation regulators in glaucoma surgery: a clinicoimmunological study

机译:使用生理擦除调节剂在青光眼外科:临床免疫学研究

获取原文
获取原文并翻译 | 示例
           

摘要

The paper presents the comparative results of clinical and immunological studies dealing with the use of the physiological reparation regulators (the human amniotic membrane and systemic enzyme therapy) and the antimetabolite 5-fluorouracil (5-FU) to prevent excessive ocular tissue scarring. The clinical observations have demonstrated the high efficiency of the proposed methods for the physiological regulation of reparative processes as compared with the use of 5-FU, which manifested as a more marked normalization ofophthalmotonus and fewer numbers of postoperative complications. The investigation of the study of proliferation-activating cytokine (TGF-beta1) and antiprolerative cytokine (IFN-gamma) has demonstrated the immunomodulating properties of the physiological reparation regulators used in the present study.
机译:本文提出了处理使用生理恢复调节剂(人羊膜和全身酶治疗)和抗体刚火素5-氟尿嘧啶(5-FU)来防止过量的眼部组织瘢痕的临床和免疫学研究的比较结果。 临床观察表明,与使用5-FU相比,临床观察结果的生理调节方法的高效率,这表现为of thalmotonus和术后并发症数量较少的术语术语。 激活细胞因子(TGF-BETA1)和抗扶手细胞因子(IFN-GAMMA)研究的研究已经证明了本研究中使用的生理擦除调节剂的免疫调节性质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号